Alcon AG | ALC - Ebit

Stock Price
66.82
Daily Change
2.56 3.98%
Monthly
6.64%
Yearly
-20.94%
Q1 Forecast
62.72

Alcon AG reported $334M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR -399M 363M Sep/2025
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 502M 168M Dec/2024